Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-001531
Filing Date
2019-03-22
Accepted
2019-03-22 12:03:22
Documents
6
Period of Report
2019-05-01
Effectiveness Date
2019-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238104zdef14a.htm DEF 14A 479423
2 G769934.JPG g769934.jpg GRAPHIC 12814
3 G263414.JPG g263414.jpg GRAPHIC 5291
4 G189424.JPG g189424.jpg GRAPHIC 3037
5 G22532BGI001.GIF g22532bgi001.gif GRAPHIC 97802
6 G22532BGI002.GIF g22532bgi002.gif GRAPHIC 103453
  Complete submission text file 0001047469-19-001531.txt   787459
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1229
Type: DEF 14A | Act: 34 | File No.: 001-35024 | Film No.: 19699009
SIC: 2833 Medicinal Chemicals & Botanical Products